Master dataINID | Criterion | Field | Content |
---|
| Type of IP right | SART | Patent |
| Status | ST | Pending/in force |
21 | DE file number | DAKZ | 60 2005 045 907.3 |
96 | EP file number | EAKZ | 05 79 2179.3 |
86 | WO file number | WAKZ | PCT/CN2005/001521 |
97 | EP publication number | EPN | 1797871 |
87 | WO publication number | WPN | 2006032202 |
54 | Designation/title | TI | LANGWIRKENDE FORMULIERUNG MIT VERZÖGERTER FREISETZUNG MIT EINEM DOPAMIN-REZEPTORAGONIST UND HERSTELLUNGSVERFAHREN DAFÜR |
51 | IPC main class | ICM (ICMV) | A61K 9/16 (2006.01) |
51 | IPC secondary class(es) | ICS (ICSV) | A61K 47/30 (2006.01), A61K 31/381 (2006.01), A61P 25/16 (2006.01), A61K 9/00 (2006.01), A61K 9/14 (2006.01), A61K 47/34 (2017.01) |
22 | DE application date | DAT | Sep 21, 2005 |
96 | EP application date | EAT | Sep 21, 2005 |
86 | WO application date | WAT | Sep 21, 2005 |
43 | Date of first publication | OT | Mar 30, 2006 |
| Date of publication of grant | PET | Feb 25, 2015 |
71/73 | Applicant/owner | INH | Geneora Pharma (Shijiazhuang) Co., Ltd., Shijiazhuang, Hebei, CN |
72 | Inventor | IN | ZHANG, LupingNo. 6-105, Dongfang Huayuan, Hunan 412000, CN |
74 | Representative | VTR | karo IP Patentanwälte PartG mbB, 40212 Düsseldorf, DE |
| Address for service | | karo IP Patentanwälte PartG mbB, 40212 Düsseldorf, DE |
33 31 32
| Foreign priority | PRC PRNA PRDA
| CN 200410077961 Sep 21, 2004
|
| Patent division in charge | | 44 |
97 | EP language of publication | ELANG | EN - Englisch |
87 | WO language of publication | WLANG | SF - Sonstige Fremdsprache |
84 | Designated EP contracting states | EDS | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR |
| Published EP/WO documents | EPWOPN | Original document:
EP000001797871 Searchable text:
EP000001797871 Original document:
EP000001797871B1 Searchable text:
EP000001797871B1 Original document:
WO002006032202 Searchable text:
WO002006032202 |
43 | Date of first publication | EVT | Mar 30, 2006 |
| Date of the first transfer into DPMAregister | EREGT | May 26, 2011 |
| Date of the (most recent) update in DPMAregister | REGT | Sep 20, 2024 (Show all update days)(Hide all update days)- Sep 20, 2024
- Aug 13, 2024
- Representative: changed
- Procedures: New representative details, New representative details, 17.02.2023: changed
- Jul 25, 2024
- Address for service: changed
- May 26, 2011
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 12)INID | Criterion | Field | Content
Close details
|
---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Feb 17, 2023 |
| Issue number | HN | 13 |
| Year | PJ | 2023 |
| Publication date | VT | Mar 30, 2023 |
| Type of publication | PART | Bibliographic data |
| Part | HT | Part 3 |
71/73 | Applicant/owner | INH | Geneora Pharma (Shijiazhuang) Co., Ltd., Shijiazhuang, Hebei, CN |
71/73 | Previous applicant/owner | INHF | Shandong Luye Pharmaceutical Co., Ltd., Yantai City, Shandong, CN |
| Date of update of the procedure | REGT | Mar 30, 2023 |